WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000029027) ANTIVIRAL FORMULATIONS COMPRISING PROPYLENE GLYCOL AND AN ISOPROPYL ALKANOIC ACID ESTER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/029027    International Application No.:    PCT/SE1999/002043
Publication Date: 25.05.2000 International Filing Date: 12.11.1999
Chapter 2 Demand Filed:    18.05.2000    
IPC:
A61K 47/14 (2006.01), A61K 47/44 (2006.01)
Applicants: MEDIVIR AB [SE/SE]; Lunastigen 7 S-141 44 Huddinge (SE) (For All Designated States Except US).
LEKARE, Gunilla [SE/SE]; (SE) (For US Only)
Inventors: LEKARE, Gunilla; (SE)
Agent: MORRISON, Iain; Medivir AB Lunastigen 7 S-141 44 Huddinge (SE)
Priority Data:
9803929-0 18.11.1998 SE
Title (EN) ANTIVIRAL FORMULATIONS COMPRISING PROPYLENE GLYCOL AND AN ISOPROPYL ALKANOIC ACID ESTER
(FR) FORMULATIONS ANTIVIRALES RENFERMANT DU PROPYLENE GLYCOL ET UN ESTER ACIDE ALKANOIQUE D'ISOPROPYLE
Abstract: front page image
(EN)A topical composition comprising an antiinflammatory glucocorticoid and a nucleoside analogue antiviral agent in a pharmaceutical carrier characterized in that the carrier comprises about 15 to about 25 weight % propylene glycol and about 10 to about 25 weight percent isopropyl C¿12?-C¿22? alkanoic ester. The compositions have utility in the treatment or prophylaxis of herpesvirus infections and exhibit superior antiviral and therapeutic efficacy and an improved shelf life.
(FR)L'invention concerne une composition topique renfermant un glucocorticoïde anti-inflammatoire et un agent antiviral d'un analogue nucléosidique dans un excipient pharmaceutique, lequel contient environ entre 15 et 25 % en poids de propylène glycol, et approximativement entre 10 et 25 % en poids d'ester alkanoïque C¿12?-C¿22? d'isopropyle. Les compositions de cette invention, qui peuvent être utilisées pour traiter ou prévenir les infections à herpèsvirus, présentent une efficacité antivirale et thérapeutique améliorée et une durée de conservation prolongée.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)